Grant Gregory A, Xu Xiao Lan, Hu Zhiqin
Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
J Biol Chem. 2004 Apr 2;279(14):13452-60. doi: 10.1074/jbc.M313593200. Epub 2004 Jan 12.
A set of asymmetric hybrid tetramers of Escherichia coli d-3-phosphoglycerate dehydrogenase (PGDH) have been made by gene co-expression and KSCN-induced dimer exchange. These tetramers contain varied numbers of active sites and effector binding sites arranged in different orientations within the tetramer. They reveal that PGDH displays half-of-the-sites activity with respect to its active sites and that the two sites that are active at any particular time lie in subunits on either side of the nucleotide binding domain interface. Half-of-the-sites functionality is also observed for the effector even though all four sites eventually bind effector. That is, only two effector sites need to be occupied for maximum inhibition. Binding of the last two effector molecules does not contribute functionally to inhibition of activity. Furthermore, positive cooperativity of inhibition of activity by the effector is completely dependent on the positive cooperativity of binding of the effector. Binding of the first effector molecule produces a conformational change that essentially completely inhibits the active site within the subunit to which it binds and produces an approximate 33% inhibition of the active site in the subunit to which it is not bound. Binding of the second effector at the opposite regulatory domain interface completes the inhibition of activity. This simple relationship defines the positional and quantitative influence of effector ligand binding on activity and can be used to predict the maximum level of inhibition of individual hybrid tetramers. In addition, the site-specific quantitative relationship of effector binding to individual active sites can be used to model the inhibition profile with relatively good agreement. These simple rules for the site to site interaction in PGDH provide significant new insight into the mechanism of allostery of this enzyme.
通过基因共表达和KSCN诱导的二聚体交换,制备了一组大肠杆菌d-3-磷酸甘油酸脱氢酶(PGDH)的不对称杂合四聚体。这些四聚体含有数量不同的活性位点和效应物结合位点,它们在四聚体内以不同方向排列。结果表明,PGDH的活性位点表现出半位点活性,且在任何特定时间处于活性状态的两个位点位于核苷酸结合结构域界面两侧的亚基中。对于效应物也观察到半位点功能,尽管所有四个位点最终都会结合效应物。也就是说,只需占据两个效应物位点就能实现最大程度的抑制。最后两个效应物分子的结合在功能上对活性抑制没有贡献。此外,效应物对活性抑制的正协同性完全取决于效应物结合的正协同性。第一个效应物分子的结合会引起构象变化,该变化基本上会完全抑制其结合亚基内的活性位点,并对其未结合亚基中的活性位点产生约33%的抑制。第二个效应物在相反调节结构域界面处的结合完成了对活性的抑制。这种简单的关系定义了效应物配体结合对活性的位置和定量影响,可用于预测单个杂合四聚体的最大抑制水平。此外,效应物与各个活性位点结合的位点特异性定量关系可用于模拟抑制曲线,且吻合度相对较好。PGDH中位点与位点相互作用的这些简单规则为该酶的变构机制提供了重要的新见解。